127 related articles for article (PubMed ID: 1656460)
1. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells.
Mack DH; Laimins LA
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9102-6. PubMed ID: 1656460
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
[TBL] [Abstract][Full Text] [Related]
5. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription.
Chong T; Apt D; Gloss B; Isa M; Bernard HU
J Virol; 1991 Nov; 65(11):5933-43. PubMed ID: 1656080
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16.
Apt D; Chong T; Liu Y; Bernard HU
J Virol; 1993 Aug; 67(8):4455-63. PubMed ID: 8392590
[TBL] [Abstract][Full Text] [Related]
7. A cell-type-specific transcription enhancer of type 16 human papillomavirus (HPV 16)-P97 promoter is defined with HPV-associated cellular events in human epithelial cell lines.
Taniguchi A; Kikuchi K; Nagata K; Yasumoto S
Virology; 1993 Aug; 195(2):500-10. PubMed ID: 8393236
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.
Sen E; Alam S; Meyers C
J Virol; 2004 Jan; 78(2):612-29. PubMed ID: 14694093
[TBL] [Abstract][Full Text] [Related]
9. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
10. Different stability of AP1 proteins in human keratinocyte and fibroblast cells: possible role in the cell-type specific expression of human papillomavirus type 18 genes.
Offord EA; Chappuis PO; Beard P
Carcinogenesis; 1993 Dec; 14(12):2447-55. PubMed ID: 8269611
[TBL] [Abstract][Full Text] [Related]
11. Methylation sensitivity of the enhancer from the human papillomavirus type 16.
List HJ; Patzel V; Zeidler U; Schopen A; Rühl G; Stollwerk J; Klock G
J Biol Chem; 1994 Apr; 269(16):11902-11. PubMed ID: 8163489
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.
Chong T; Chan WK; Bernard HU
Nucleic Acids Res; 1990 Feb; 18(3):465-70. PubMed ID: 2155400
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
Peto M; Tolle-Ersü I; Kreysch HG; Klock G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
[TBL] [Abstract][Full Text] [Related]
14. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1.
Bauknecht T; Angel P; Royer HD; zur Hausen H
EMBO J; 1992 Dec; 11(12):4607-17. PubMed ID: 1330541
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional control and cell type specificity of HPV gene expression.
Bernard HU; Apt D
Arch Dermatol; 1994 Feb; 130(2):210-5. PubMed ID: 8304760
[TBL] [Abstract][Full Text] [Related]
16. A multiprotein complex consisting of the cellular coactivator p300, AP-1/ATF, as well as NF-kappaB is responsible for the activation of the mouse major histocompatibility class I (H-2K(b)) enhancer A.
Brockmann D; Pützer BM; Lipinski KS; Schmücker U; Esche H
Gene Expr; 1999; 8(1):1-18. PubMed ID: 10543727
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the control of expression and tissue specificity of the keratin 5 gene, characteristic of basal keratinocytes. Fundamental role of an AP-1 element.
Casatorres J; Navarro JM; Blessing M; Jorcano JL
J Biol Chem; 1994 Aug; 269(32):20489-96. PubMed ID: 7519609
[TBL] [Abstract][Full Text] [Related]
18. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes.
Parker JN; Zhao W; Askins KJ; Broker TR; Chow LT
Cell Growth Differ; 1997 Jul; 8(7):751-62. PubMed ID: 9218869
[TBL] [Abstract][Full Text] [Related]
19. A distal element in the HPV-11 upstream regulatory region contributes to promoter repression in basal keratinocytes in squamous epithelium.
Zhao W; Chow LT; Broker TR
Virology; 1999 Jan; 253(2):219-29. PubMed ID: 9918880
[TBL] [Abstract][Full Text] [Related]
20. Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner.
Apt D; Liu Y; Bernard HU
Nucleic Acids Res; 1994 Sep; 22(19):3825-33. PubMed ID: 7937100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
